Innoviva Inc (INVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INVA | LLY | NVO | JNJ | ABBV |
| Company | Innoviva Inc | Eli Lilly and Company | Novo Nordisk A/S ADR | Johnson & Johnson | Abbvie Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NYSE | NYSE |
| Open | 19.20 | 746.12 | 103.18 | 153.62 | 168.59 |
| High | 19.26 | 749.92 | 103.18 | 155.79 | 172.09 |
| Low | 18.98 | 735.00 | 101.51 | 152.81 | 166.92 |
| Last | 19.28 | 750.32 | 103.11 | 155.61 | 172.06 |
| Change | +0.13 | -3.09 | -2.16 | +2.50 | +4.30 |
| % Change | +0.68% | -0.41% | -2.05% | +1.63% | +2.56% |
| Volume | 264,481 | 2,124,819 | 3,469,395 | 3,579,812 | 3,126,002 |
| 20-Day Average Volume | 709,796 | 5,429,006 | 6,597,405 | 7,066,080 | 7,367,047 |
| Previous Close | 19.15 | 753.41 | 105.27 | 153.11 | 167.76 |
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 19.60 | 807.97 | 107.78 | 156.64 | 185.11 |
| 20-Day Raw Stochastic | 28.30% | 18.92% | 23.85% | 34.84% | 18.25% |
| 20-Day Relative Strength | 45.52% | 33.66% | 35.51% | 43.28% | 36.46% |
| Weighted Alpha | +35.59 | +10.40 | -13.61 | +0.73 | +12.50 |
| Today's Opinion | 40% Buy | 56% Sell | 100% Sell | 24% Sell | 24% Sell |
| Previous Opinion | 56% Buy | 56% Sell | 100% Sell | 24% Sell | 24% Sell |
| Last Month's Opinion | 100% Buy | 40% Buy | 88% Sell | 88% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.13% since 11/14/24 | -4.79% since 11/14/24 | -2.26% since 11/14/24 | +2.29% since 11/14/24 | +1.25% since 11/14/24 |
| Low | 18.77 on 11/15/24 | 711.40 on 11/18/24 | 99.42 on 11/18/24 | 150.90 on 11/15/24 | 163.81 on 11/19/24 |
| High | 19.31 on 11/19/24 | 777.98 on 11/15/24 | 105.74 on 11/20/24 | 155.52 on 11/21/24 | 172.06 on 11/21/24 |
| 1-Month | |||||
| %Chg | -3.20% since 10/21/24 | -17.39% since 10/21/24 | -12.26% since 10/21/24 | -4.60% since 10/21/24 | -7.93% since 10/21/24 |
| Low | 18.40 on 11/14/24 | 711.40 on 11/18/24 | 99.42 on 11/18/24 | 150.76 on 11/14/24 | 163.81 on 11/19/24 |
| High | 21.28 on 11/12/24 | 911.12 on 10/22/24 | 116.65 on 10/22/24 | 166.00 on 10/23/24 | 207.32 on 10/31/24 |
| 3-Month | |||||
| %Chg | +3.58% since 08/21/24 | -21.36% since 08/21/24 | -23.72% since 08/21/24 | -3.77% since 08/21/24 | -12.61% since 08/21/24 |
| Low | 18.40 on 11/14/24 | 711.40 on 11/18/24 | 99.42 on 11/18/24 | 150.76 on 11/14/24 | 163.81 on 11/19/24 |
| High | 21.28 on 11/12/24 | 972.53 on 08/22/24 | 139.74 on 08/30/24 | 168.85 on 09/04/24 | 207.32 on 10/31/24 |
| 6-Month | |||||
| %Chg | +18.98% since 05/21/24 | -6.80% since 05/21/24 | -23.84% since 05/21/24 | +2.71% since 05/21/24 | +5.41% since 05/21/24 |
| Low | 15.20 on 05/29/24 | 711.40 on 11/18/24 | 99.42 on 11/18/24 | 143.71 on 05/29/24 | 153.58 on 05/30/24 |
| High | 21.28 on 11/12/24 | 972.53 on 08/22/24 | 148.15 on 06/25/24 | 168.85 on 09/04/24 | 207.32 on 10/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,198,809 | 715,224,192 | 472,402,528 | 368,631,168 | 296,455,392 |
| Shares Outstanding, K | 62,601 | 949,316 | 4,487,532 | 2,407,623 | 1,767,140 |
| Annual Sales | 310,460,000 | 34,124,100,000 | 33,724,300,000 | 85,159,000,000 | 54,318,000,000 |
| Annual Net Income | 179,720,000 | 5,240,400,000 | 12,150,770,000 | 35,153,000,000 | 4,863,000,000 |
| Last Quarter Sales | 89,510,000 | 11,439,100,000 | 10,511,240,000 | 22,471,000,000 | 14,460,000,000 |
| Last Quarter Net Income | 1,210,000 | 970,300,000 | 4,024,170,000 | 2,694,000,000 | 1,561,000,000 |
| 60-Month Beta | 0.57 | 0.43 | 0.42 | 0.53 | 0.63 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.02 on 11/06/24 | 1.18 on 10/30/24 | 0.90 on 11/06/24 | 2.42 on 10/15/24 | 3.00 on 10/30/24 |
| Latest Earnings Date | 11/06/24 | 10/30/24 | 11/06/24 | 10/15/24 | 10/30/24 |
| Most Recent Dividend | 0.250 on 09/08/15 | 1.300 on 11/15/24 | 0.362 on 08/16/24 | 1.240 on 08/27/24 | 1.550 on 10/15/24 |
| Next Ex-Dividends Date | 09/08/15 | 11/15/24 | 08/16/24 | 11/26/24 | 01/15/25 |
| Ratios | |||||
| Price/Earnings ttm | 9.94 | 71.75 | 33.21 | 14.94 | 15.49 |